An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule

Sci Rep. 2015 Dec 21:5:18450. doi: 10.1038/srep18450.

Abstract

Host defence peptides (HDPs) are critical components of innate immunity. Despite their diversity, they share common features including a structural signature, designated "γ-core motif". We reasoned that for each HDPs evolved from an ancestral γ-core, the latter should be the evolutionary starting point of the molecule, i.e. it should represent a structural scaffold for the modular construction of the full-length molecule, and possess biological properties. We explored the γ-core of human β-defensin 3 (HBD3) and found that it: (a) is the folding nucleus of HBD3; (b) folds rapidly and is stable in human serum; (c) displays antibacterial activity; (d) binds to CD98, which mediates HBD3 internalization in eukaryotic cells; (e) exerts antiviral activity against human immunodeficiency virus and herpes simplex virus; and (f) is not toxic to human cells. These results demonstrate that the γ-core within HBD3 is the ancestral core of the full-length molecule and is a viable HDP per se, since it is endowed with the most important biological features of HBD3. Notably, the small, stable scaffold of the HBD3 γ-core can be exploited to design disease-specific antimicrobial agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs / genetics*
  • Anti-Infective Agents / metabolism*
  • Anti-Infective Agents / therapeutic use
  • Antiviral Agents / metabolism
  • Antiviral Agents / therapeutic use
  • Fusion Regulatory Protein-1 / chemistry
  • Fusion Regulatory Protein-1 / metabolism
  • HIV-1 / drug effects
  • Humans
  • Immunity, Innate / genetics*
  • Peptides / chemistry
  • Peptides / metabolism
  • Protein Binding
  • Protein Folding
  • Simplexvirus / drug effects
  • beta-Defensins / chemistry
  • beta-Defensins / genetics
  • beta-Defensins / metabolism*

Substances

  • Anti-Infective Agents
  • Antiviral Agents
  • DEFB103A protein, human
  • Fusion Regulatory Protein-1
  • Peptides
  • beta-Defensins